column
    A Tale of Distinct Tumor Evolutionary Paths from A Tumor Cell Line
    CAI Wei-jing
    2016, 16(2): 65-66. DOI: 10.12019/j.issn.1671-5144.2016.02.001
    Abstract PDF
    Clonal Neoantigens Elicit T Cell Immunoreactivity and Sensitivity to Immune Checkpoint Blockade
    DONG Zhong-yi, ZHONG Wen-zhao
    2016, 16(2): 67-67. DOI: 10.12019/j.issn.1671-5144.2016.02.002
    Abstract PDF
    The Rising Star of Lung Cancer Targeted Therapy: MET exon14? skipping
    LIU Xue-wen
    2016, 16(2): 68-69. DOI: 10.12019/j.issn.1671-5144.2016.02.003
    Abstract PDF
    Recent Advances in the Treatment of Elderly Patients with Mantle Cell Lymphoma
    WANG Xiao-xiao, HUANG Hui-qiang
    2016, 16(2): 70-72. DOI: 10.12019/j.issn.1671-5144.2016.02.004
    Abstract PDF
    Efficacy and Safety of Bendamustine plus Rituximab Compared with CHOP plus Rituximab as First-Line Treatment for Patients with Indolent Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
    ZHANG Xin-yu, XU Wei, LIU Si-chu
    2016, 16(2): 73-75. DOI: 10.12019/j.issn.1671-5144.2016.02.005
    Abstract PDF
    Induction Therapy with R ? CHOP and R ? FC in Older Mantle Cell Lymphoma Patients Received Maintenance Therapy with Interferon Alfa and Rituximab
    LI Wen-yu, Literature Co-worker: HUANG Ling
    2016, 16(2): 76-79. DOI: 10.12019/j.issn.1671-5144.2016.02.006
    Abstract PDF
    The Beginning of Non-Chemotherapy Era: Lenalidomide plus Rituximab as First-Line Therapy for Mantle-Cell Lymphoma
    Reviewer: SONG Yu-qin, Literature Co-worker: CAI Qi-chun
    2016, 16(2): 80-82. DOI: 10.12019/j.issn.1671-5144.2016.02.007
    Abstract PDF
    Bortezomib-Based Therapy for Newly Diagnosed Older Mantle-Cell Lymphoma Patients
    Reviewers: NIE Man, LI Zhi-ming, Literature Co-worker: WEI Xiao-juan
    2016, 16(2): 83-85. DOI: 10.12019/j.issn.1671-5144.2016.02.008
    Abstract PDF
    Association between Mh Infection Andadverse Pregnancy Outcome: A Meta-Analysis
    XU Min, YU Hong, ZHOU Jin, WANG Bei
    2016, 16(2): 86-92. DOI: 10.12019/j.issn.1671-5144.2016.02.009
    Abstract PDF
    Analysis of Serum Bilirubin and Protein on Dry Chemical System among Healthy Children and Adolescents in Shenzhen
    CAO Ke, LUO Xiao-juan, MA Dong-li, LAI Jian-wei, LIU Xin-gang, Huang Bao-xing, CHEN Yun-sheng
    2016, 16(2): 93-96. DOI: 10.12019/j.issn.1671-5144.2016.02.010
    Abstract PDF
    Effect of Different Doses of Continuous Blood Purification on the Prognosis of Patients with Severe Acute Kidney Injury
    FU Xia, LIANG Xin-ling, SONG Li, CHEN Yuan-han, QIU Bi-hui, QUAN Zi-lin, SHI Wei
    2016, 16(2): 97-102. DOI: 10.12019/j.issn.1671-5144.2016.02.011
    Abstract PDF
    Exploring the Individualized Treatment of Bronchiectasis by Traditional Chinese Medicine through N-of-1 Trials
    XUE Jing-jing, YANG Pei-lan, WANG Jie, TANG Jie, DING Li-yu, MA Ying, Gordon H. Guyatt, ZHANG Yu-qing
    2016, 16(2): 103-108. DOI: 10.12019/j.issn.1671-5144.2016.02.012
    Abstract PDF
    Prevention of Post Intubation Airway Complications by Inflating Endotracheal Tube Cuff with Lidocaine: A Systematic Review
    LI An-liang, GAO Hong, LIN Shao-feng, LIU Yan-qiu
    2016, 16(2): 110-115. DOI: 10.12019/j.issn.1671-5144.2016.02.013
    Abstract PDF
    Assessment the Quality of Life in Hemodialysis Patients with HBV
    ZHAO Li-yan, SONG Li, PENG Yin-yan, QUAN Zi-lin, CHEN Cheng, ZHOU You, CUI Dong-mei, FU Xia
    2016, 16(2): 116-118. DOI: 10.12019/j.issn.1671-5144.2016.02.014
    Abstract PDF
    The Recent Development of Research for Breast Cancer Neoadjuvant Endocrine Therapy
    CHENG Min-yi, WANG Kun
    2016, 16(2): 119-124. DOI: 10.12019/j.issn.1671-5144.2016.02.015
    Abstract PDF
    Children’s Acute Lymphoblastic Leukemia Combined with Central Nervous System Lesions//Zong Sa, LIN Yu-deng
    Zong Sa, LIN Yu?deng
    2016, 16(2): 125-128. DOI: 10.12019/j.issn.1671-5144.2016.02.016
    Abstract PDF